Professor claims Eli Lilly's tirzepatide could essentially eradicate type 2 diabetes

Professor and consultant Sten Madsbad says that the treatment could be a new start for type 2 diabetes sufferers.
Photo: Morten Germund/Morten Germund /
Photo: Morten Germund/Morten Germund /
by andreas lønstrup, translated by catherine brett

Eli Lilly’s tirzepatide is ”a new start” within type 2 diabetes and could essentially eradicate the disease, professor Sten Madsbad, who is a consultant at the endocrinology department at Hvidovre hospital, tells Danish journal Sundhedspolitisk Tidsskrift.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading